Protein kinase C modulators influence meiosis kinetics but not fertilizability of mouse oocytes.
The role of protein kinase C (PKC) in the successive steps of mouse oocyte meiotic process was investigated. We have used either OAG, an analog of diacylglycerol, or mezerein, a nonphorbol ester diterpene, less tumor promoting than phorbol esters, as PKC activators, and staurosporine as PKC inhibitor. Cumulus-free oocytes were cultured in minimum essential medium with each of these PKC modulators and maturation stages were screened every two hours until the end of the process. Both PKC activators prevented GVBD at each tested dose for 4 hr (OAG) and 8 hr (mezerein), and decreased the frequencies of PB oocytes. The inhibitory effects of both activators were dose dependent and reversible. The addition of OAG to the culture medium after GVBD occurrence (i.e., after 4 hrs) did not affect PB extrusion whereas similar addition of mezerein significantly decreased the frequency of PB oocytes. Inhibition of PKC by staurosporine accelerated GVBD and increased the frequency of PB extrusion. When staurosporine was added after GVBD, PB extrusion occurred earlier but PB oocyte frequency was not increased. Fertilizability was not affected when oocyte maturation occurred in the presence of any of these substances despite the delay in maturation process. These results clearly indicate that the PKC pathway is involved in mouse oocyte meiotic process: activation of the enzyme would arrest meiotic process whereas its inhibition would participate in meiosis induction.
Lefèvre
B
B
INSERM, 92140-Clamart, France.
Pesty
A
A
Koziak
K
K
Testart
J
J
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D004075:Diglycerides / Q000494:pharmacology; D004224:Diterpenes; D005298:Fertility / Q000187:drug effects; D007700:Kinetics; D008540:Meiosis / Q000502:physiology*; D051379:Mice; D009865:Oocytes / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D019311:Staurosporine; D013729:Terpenes / Q000494:pharmacology
D000470:Alkaloids; D004075:Diglycerides; D004224:Diterpenes; D013729:Terpenes; C011309:mezerein; D011493:Protein Kinase C; D019311:Staurosporine